These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 18606313)
1. The changes of the cardiac structure and function in cTnTR141W transgenic mice. Juan F; Wei D; Xiongzhi Q; Ran D; Chunmei M; Lan H; Chuan Q; Lianfeng Z Int J Cardiol; 2008 Aug; 128(1):83-90. PubMed ID: 18606313 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Lu D; Ma Y; Zhang W; Bao D; Dong W; Lian H; Huang L; Zhang L Hypertension; 2012 Jul; 60(1):81-9. PubMed ID: 22665122 [TBL] [Abstract][Full Text] [Related]
6. Calponin1 inhibits dilated cardiomyopathy development in mice through the εPKC pathway. Lu D; Zhang L; Bao D; Lu Y; Zhang X; Liu N; Ge W; Gao X; Li H; Zhang L Int J Cardiol; 2014 May; 173(2):146-53. PubMed ID: 24631115 [TBL] [Abstract][Full Text] [Related]
7. Expression of CYP2E1 increases oxidative stress and induces apoptosis of cardiomyocytes in transgenic mice. Zhang W; Lu D; Dong W; Zhang L; Zhang X; Quan X; Ma C; Lian H; Zhang L FEBS J; 2011 May; 278(9):1484-92. PubMed ID: 21352494 [TBL] [Abstract][Full Text] [Related]
8. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model. Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225 [TBL] [Abstract][Full Text] [Related]
9. Human umbilical cord blood derived mesenchymal stem cells improve cardiac function in cTnT(R141W) transgenic mouse of dilated cardiomyopathy. Gong X; Wang P; Wu Q; Wang S; Yu L; Wang G Eur J Cell Biol; 2016 Jan; 95(1):57-67. PubMed ID: 26655348 [TBL] [Abstract][Full Text] [Related]
10. Cardioprotection by Hepc1 in cTnT(R141W) transgenic mice. Zhang L; Lu D; Zhang W; Quan X; Dong W; Xu Y; Zhang L Transgenic Res; 2012 Aug; 21(4):867-78. PubMed ID: 22198484 [TBL] [Abstract][Full Text] [Related]
11. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Parlakian A; Charvet C; Escoubet B; Mericskay M; Molkentin JD; Gary-Bobo G; De Windt LJ; Ludosky MA; Paulin D; Daegelen D; Tuil D; Li Z Circulation; 2005 Nov; 112(19):2930-9. PubMed ID: 16260633 [TBL] [Abstract][Full Text] [Related]
12. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside-Rb1 and tetramethylpyrazine phosphate act synergistically to prevent dilated cardiomyopathy in cTnTR141W transgenic mice. Lu D; Shao HT; Ge WP; Liu N; Zhang X; Ma CM; Qin C; Zhang LF J Cardiovasc Pharmacol; 2012 May; 59(5):426-33. PubMed ID: 22240916 [TBL] [Abstract][Full Text] [Related]
14. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Funakoshi H; Chan TO; Good JC; Libonati JR; Piuhola J; Chen X; MacDonnell SM; Lee LL; Herrmann DE; Zhang J; Martini J; Palmer TM; Sanbe A; Robbins J; Houser SR; Koch WJ; Feldman AM Circulation; 2006 Nov; 114(21):2240-50. PubMed ID: 17088462 [TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization. Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368 [TBL] [Abstract][Full Text] [Related]
16. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44). Edes IF; Tóth A; Csányi G; Lomnicka M; Chłopicki S; Edes I; Papp Z J Mol Cell Cardiol; 2008 Sep; 45(3):363-72. PubMed ID: 18674539 [TBL] [Abstract][Full Text] [Related]
17. Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway. Lu D; Bao D; Dong W; Liu N; Zhang X; Gao S; Ge W; Gao X; Zhang L Lab Invest; 2016 Feb; 96(2):239-48. PubMed ID: 26641069 [TBL] [Abstract][Full Text] [Related]
18. Persistent hyperplastic primary vitreous in transgenic mice expressing IE180 of the pseudorabies virus. Taharaguchi S; Yoshida K; Tomioka Y; Yoshino S; Uede T; Ono E Invest Ophthalmol Vis Sci; 2005 May; 46(5):1551-6. PubMed ID: 15851549 [TBL] [Abstract][Full Text] [Related]
19. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice. Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321 [TBL] [Abstract][Full Text] [Related]
20. Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a. Hesse M; Kondo CS; Clark RB; Su L; Allen FL; Geary-Joo CT; Kunnathu S; Severson DL; Nygren A; Giles WR; Cross JC Cardiovasc Res; 2007 Aug; 75(3):498-509. PubMed ID: 17512504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]